本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

481.00
+2.170.45%
盘后479.02-1.9800-0.41%17:23 EST
成交量:29.82万
成交额:1.42亿
市值:109.24亿
市盈率:-36.90
高:483.03
开:483.03
低:463.53
收:478.83
52周最高:615.00
52周最低:265.00
股本:2,271.14万
流通股本:1,100.01万
量比:0.78
换手率:2.71%
股息:- -
股息率:- -
每股收益(TTM):-13.0355
每股收益(LYR):-21.9007
净资产收益率:-41.22%
总资产收益率:-15.78%
市净率:17.46
市盈率(LYR):-21.96

数据加载中...

2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/09/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans